Height at diagnosis and birth-weight as risk factors for osteosarcoma
about
The epidemiology of sarcomaHigh Birth Weight Increases the Risk for Bone Tumor: A Systematic Review and Meta-AnalysisGenome-wide association study identifies two susceptibility loci for osteosarcomaGermline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.Frailty modeling of age-incidence curves of osteosarcoma and Ewing sarcoma among individuals younger than 40 yearsGRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han populationCurrent state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.Small-area analyses of bone cancer diagnosed in Great Britain provide clues to aetiology.Childhood and adolescent cancer statistics, 2014.Epidemiology and therapies for metastatic sarcomaIR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma.Effect of variation of FGF2 genotypes on the risk of osteosarcoma susceptibly: a case control study.A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with OsteosarcomaTowards cancer-aware life-history modellingBirth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analysesGermline TP53 variants and susceptibility to osteosarcoma.Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study.Children's Oncology Group's 2013 blueprint for research: epidemiologyOf dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma.Perinatal factors associated with clinical presentation of osteosarcoma in children and adolescents.Short hairpin RNA (shRNA) of type 2 interleukin-1 receptor (IL1R2) inhibits the proliferation of human osteosarcoma U-2 OS cells.Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.Bone cancer incidence by morphological subtype: a global assessment.MicroRNA-150 upregulation reduces osteosarcoma cell invasion and metastasis by downregulating EzrinComparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope.Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.Associations between inflammatory gene polymorphisms (TNF-α 308G/A, TNF-α 238G/A, TNF-β 252A/G, TGF-β1 29T/C, IL-6 174G/C and IL-10 1082A/G) and susceptibility to osteosarcoma: a meta-analysis and literature review.Correlations of ezrin expression with pathological characteristics and prognosis of osteosarcoma: a meta-analysis.A Bayesian Gene-Based Genome-Wide Association Study Analysis of Osteosarcoma Trio Data Using a Hierarchically Structured Prior.Identification of Key Genes and miRNAs in Osteosarcoma Patients with Chemoresistance by Bioinformatics Analysis.Osteosarcoma in patients below 25 years of age: An observational study of incidence, metastasis, treatment and outcomes
P2860
Q21195878-D33F17EC-59FC-4073-90D0-C17C98FDA4E2Q26786940-DC00D18D-B019-41F2-8571-A840CE37F107Q28659642-F40C02C3-4EA1-4C0B-B027-C42D1F92D203Q30235105-068D1F39-E6F4-4BE5-A507-D886E308D4F3Q33737869-E5B57128-812E-484A-A52E-07A9B64120F2Q33839291-62FBEAC8-8314-4555-A910-960CB2C5713EQ33872384-4E97DB6C-924D-4EED-8F50-7F01FC72E5B8Q34318891-A9E5BC01-BE53-4483-91F0-B86FF393BE3BQ34401667-E822548B-D922-4865-A8F4-3E64BCE0EA4DQ34652142-9894B56D-AA65-4FEB-A464-2F2E5C94845FQ34728942-BAA82CFC-8DF0-44FA-AF0F-77CBDCAC6760Q35791674-97095287-95AF-4E94-A708-C35827A3348EQ36029709-1F71E50D-6EF6-4C94-8962-4212D793275CQ36088043-78BAB841-FF84-4FD1-B8BF-10F0CA83A076Q36146180-EDAED011-242E-44E6-8443-78B387491653Q36294747-5856E894-3933-43F7-BDE8-361ED4B768D3Q36429557-742F0155-3A16-4810-8296-73DB555C75D6Q37052986-EF063D4B-B0F0-474E-AF4A-51EA175AE070Q37944599-3CDF46AA-8820-449C-B25C-77AC7BDC578BQ38793873-0AFE66AA-DB8F-49FD-A9E6-C6924BA418FDQ38937091-60A38CF0-E2B9-486A-A90C-2ABC3983BBE7Q38967213-E2D636EB-BD25-4341-8079-9100BDBCD9F1Q40857727-2AD04EF8-E5F8-4589-A22B-E1D8CD52C268Q42370625-2192863B-8810-44C8-B576-64BFC71CFD48Q42634367-4CBFBBB7-9228-45D2-B8D2-3E21619080DAQ47095296-3A406DE8-2781-4D2C-93C7-951A599445C7Q47132356-0B706F42-5641-4EEA-BE30-B5B1FA058FA5Q47158760-E438E1FA-C0D4-437C-906A-F64CC95DA96BQ53657543-05675C6E-9C20-4F01-B26C-D043BC37BA2CQ55255147-89E379CA-CCDC-42EC-8E37-20EEFDB0CF22Q55258901-2676E7B6-277C-486B-A732-BFA4EF9E5791Q58572527-DA1B4484-7DFD-4A72-A11A-4E1835C1772C
P2860
Height at diagnosis and birth-weight as risk factors for osteosarcoma
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Height at diagnosis and birth-weight as risk factors for osteosarcoma
@ast
Height at diagnosis and birth-weight as risk factors for osteosarcoma
@en
type
label
Height at diagnosis and birth-weight as risk factors for osteosarcoma
@ast
Height at diagnosis and birth-weight as risk factors for osteosarcoma
@en
prefLabel
Height at diagnosis and birth-weight as risk factors for osteosarcoma
@ast
Height at diagnosis and birth-weight as risk factors for osteosarcoma
@en
P2093
P2860
P1476
Height at diagnosis and birth-weight as risk factors for osteosarcoma
@en
P2093
Alan W Craft
Ana Patiño-Garcia
Chester Douglass
Gwen Murphy
Lisa Mirabello
Najat C Daw
Rebecca J Troisi
Robert N Hoover
Ruth Pfeiffer
P2860
P2888
P304
P356
10.1007/S10552-011-9763-2
P577
2011-04-05T00:00:00Z